Leader of team responsible for business development, international growth, partnerships and strategy for enterprise imaging, cloud, real world data and AI.

Business leader for IBM Watson Health’s Global Provider business, including medical imaging, analytics, data and pharmacy solutions.Vice President of Sales and Business Development at Merge Healthcare - acquired by IBMVice President of Sales and Marketing at DR Systems - acquired by Merge Healthcare

Boutique consulting firm focusing on marketing, IP strategy, due diligence, valuation, interim executive services, business development, business planning, M&A and capital strategies.Led engagements including companies focused in cloud (networking), analytics, energy, consumer electronics, social networking, internet of things (IoT) and venture investment markets.

Member of management team that led formerly Cardiff Software through two accretive acquisitions, including playing a major role in substantial organic revenue growth during aggressive synergy and integration phases of acquisitions.As Director of Marketing and Product Management, repositioned company from small ASP deal focus to enterprise Business Process Management (BPM) solution via roadmap, IP acquisition, sales team and tools evolution, evangelism and analyst coverage. Directed worldwide product, marcom, alliance and channel marketing including leading co-marketing.Subject Matter Expert of AI-driven Information Governance and compliance. Drove awareness and Fortune 500 deal pipeline for big data analytics-based security and compliance solution.As Director of Business Development, created strategic revenue sources by directing the team responsible for identifying and negotiating OEM partner business, positioning and highlighting products as toolkits and developer platforms. Key vertical markets and solution areas included: Healthcare IT/IS, Financial Services and Content Management.Autonomy acquired by HP (HPQ)

Co-founder of fabless semiconductor company. Negotiated the extensive patent, human capital and technology transfer deal with Lucent/Agere that was the basis for the formation of Enpirion and its acquisition by Altera.Created business plan and actively co-led VC raise and negotiations resulting in Series A funding during early 2000’s tech downturn when early stage investments were rare. Responsible for major account engagements including Intel, Dell, Microsoft and others. Markets of focus included wireless, networking and computing.Acquired by Altera.

Directed North America marketing group responsible for the mobile and computing segments, enabling Hitachi to exceed revenue targets for these solutions. Led application engineering team engaged in building reference designs, development tools, developer platforms and field sales support.Directed Business Development team that managed the global Microsoft alliance to the CEO level resulting in winning 5 of 7 first generation Windows Mobile (CE) designs with major OEMs including HP, LG and Acer and provided Hitachi the leadership position in automotive information systems.Initiated spin-off of a technology licensing company for Hitachi’s core microprocessor IP.Engaged Hitachi in the creation and deal identification for a large venture fund to gain foothold in Silicon Valley IP.

One of the first companies to develop and market research-grade high resolution digital cameras commercially. Primary markets were imaging in physical and biological sciences. ISIS also developed imaging and data analytics software which was sub-licensed by companies such as Raytheon.Role included managing all product development, marketing and sales programs. Key charter was growth through penetration of new markets such as pathology and genomic imaging.

IPO. Early employee, hired as the first product-focused engineer. Led the development of the company’s first system-level commercial products primarily focused on magnetic imaging for medical and physical sciences.

Developed research system hardware and software for novel imaging solutions.